Position paper ANMCO: Diagnosi e trattamento dello scompenso cardiaco a funzione sistolica preservata

Heart failure is the leading cardiovascular cause of hospitalization with an increasing prevalence, especially in older patients. About 50% of patients with heart failure have preserved ventricular function, a form of heart failure that, until a few years ago, was orphaned by pharmacological treatments effective in reducing hospitalization and mortality. New trials, which have tested the use of gliflozins in patients with heart failure with preserved ejection fraction (HFpEF), have for the first time demonstrated their effectiveness in changing the natural history of this insidious and frequent form of heart failure. Therefore, diagnosing those patients early is crucial to provide the best treatment. Moreover, the diagnosis is influenced by the patient's comorbidities, and some HFpEF patients have symptoms common to other rare diseases that, if unrecognized, develop an unfavourable prognosis. This position paper aims to provide the clinician with a useful tool for diagnosing and treating patients with HFpEF, guiding the clinician towards the most appropriate diagnostic and therapeutic pathway.

Authors

Institutions

Publication Details

Journal
Giornale italiano di cardiologia
Published
2025-04-01
DOI
https://doi.org/10.1714/4464.44616
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Position paper ANMCO: Diagnosi e trattamento dello scompenso cardiaco a funzione sistolica preservata

Alessandro Navazio, Massimo Grimaldi, Attilio Iacovoni, Giuseppe Di Tano et al.
Giornale italiano di cardiologia
Cardiovascular Function and Risk Factors
article

Position paper ANMCO: Diagnosi e trattamento dello scompenso cardiaco a funzione sistolica preservata

Alessandro Navazio, Massimo Grimaldi, Attilio Iacovoni, Giuseppe Di Tano, Filippo Zilio, Vittorio Pascale, Cristina Chimenti, Alfonso Iorio, Claudio Bilato, Michele Massimo Gulizia, Manlio Cipriani, Massimo Iacoviello, Emanuele Tizzani, Furio Colivicchi, Gian Francesco Mureddu, Domenico Gabrielli, Federico Nardi, Pietro Scicchitano, Leonardo De Luca, Mauro Gori, Marco Marini, Giovanna Geraci, Andrea Mortara, Carmine Riccio, Andrea Di Lenarda, Fabrizio Oliva, Marco Corda, Massimo Milli, Michele Senni, Massimo Di Marco
article en

Abstract

Heart failure is the leading cardiovascular cause of hospitalization with an increasing prevalence, especially in older patients. About 50% of patients with heart failure have preserved ventricular function, a form of heart failure that, until a few years ago, was orphaned by pharmacological treatments effective in reducing hospitalization and mortality. New trials, which have tested the use of gliflozins in patients with heart failure with preserved ejection fraction (HFpEF), have for the first time demonstrated their effectiveness in changing the natural history of this insidious and frequent form of heart failure. Therefore, diagnosing those patients early is crucial to provide the best treatment. Moreover, the diagnosis is influenced by the patient's comorbidities, and some HFpEF patients have symptoms common to other rare diseases that, if unrecognized, develop an unfavourable prognosis. This position paper aims to provide the clinician with a useful tool for diagnosing and treating patients with HFpEF, guiding the clinician towards the most appropriate diagnostic and therapeutic pathway.

Giornale italiano di cardiologiaVol. 26(4)
Altera (United States) (US), Azienda Ospedaliera San Giovanni Addolorata (IT), Policlinico Umberto I (IT), Ospedale Santa Chiara (IT), Ospedali Riuniti di Foggia (IT), Società Italiana di Cardiologia (IT), Azienda Ospedaliera San Camillo-Forlanini (IT), Associazione Nazionale Medici Cardiologi Ospedalieri (IT), AULSS 2 Marca Trevigiana (IT), Ospedale San Filippo Neri (IT), Azienda Sanitaria di Firenze (IT), Nuovo Ospedale San Giovanni di Dio (IT), Ospedale Garibaldi (IT), Ospedale Papa Giovanni XXIII (IT), Ospedale di Santo Spirito (IT), Presidio Ospedaliero (IT), Azienda Ospedaliera S.Maria (IT), Policlinico Universitario di Catania (IT), Ospedale Generale Regionale Francesco Miulli (IT), Azienda di Rilievo Nazionale ed Alta Specializzazione (IT), Azienda Ospedaliera Pugliese Ciaccio (IT), Ospedale Sant'Anna (IT), Policlinico San Matteo Fondazione (IT), Ospedale degli Infermi (IT), Azienda Usl Toscana Centro (IT), Azienda Sanitaria Universitaria Integrata di Trieste (IT), Istituti Ospitalieri di Cremona (IT), Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IT)
Openalex Percentile: Top 91%
Cardiovascular Function and Risk Factors
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.